
|Articles|January 15, 2004
Inspire Pharmaceuticals to launch epinastine
Irvine, CA-Allergan Inc. and Inspire Pharmaceuticals Inc. will jointly promote epinastine HCl ophthalmic solution 0.05% (Elestat), with Inspire taking on primary duties for sales, promotion, and marketing.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Looking back at the 2025 EnVision Summit
4
Last year in glaucoma at EnVision Summit 2025
5




























